Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boswellia Cream for Radiation-Induced Dermatitis in Head and Neck Cancer
NCT07778290Recruiting
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label trial of boswellia serrata in radiodermatitis (2 arms). Primary endpoints: Proportion of patients requiring rescue treatment up to 11 weeks and Proportion of patients with improved skin condition at 7 weeks. Started Aug 2026; status: recruiting.
02
Drugs
boswellia serrata
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on NCT07778290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778290.